Clinical Investigations: Acute Ischemic Heart DiseaseLeft ventricular function in atrial fibrillation during overdrive pacing*,**,★
Section snippets
Study protocol
Eighteen patients with previously placed permanent ventricular pacemakers and documented chronic AF were recruited from the John Dempsey and Grove Hill Cardiology pacemaker services. Patients with left bundle branch block at baseline were excluded from the study. All pacemaker leads were placed within the right ventricular apex. Standard 2-dimensional echocardiography was performed with a Hewlett-Packard Sonos 2500 echocardiograph (Palo Alto, Calif). Left atrial size was estimated with standard
Results
The clinical characteristics and baseline echocardiographic measurements for each patient are presented in Table I.Patient Age Sex AF etiology Medications LA size (cm) LV Fn 1 74 F HTN D 4.0 ↓ ↓ 2 74 M HTN A,C,D 4.5 ↓ ↓ 3 82 M HTN, CAD A,B,D 5.5 ↓ ↓ 4 72 M HTN C,ARB 4.6 ↓ ↓ 5 90 M HTN A,D 4.0 ↓ 6 90 M HTN, CAD A,D,G 4.0 ↓ ↓ 7 75 M HTN, CAD B 3.9 ↓ ↓ 8 85 M HTN A,C 4.0 Normal 9 82 F HTN A,D,G 4.6 ↓ ↓ 10 89 M HTN, CAD A,B,D 4.5 Normal 11 76 M HTN 4.5 Normal 12 73 M HTN, CAD A,B,C,D 4.3 Normal 13 40 M HTN C,D 4.4 ↓ 14 83 F HTN C,D 4.1 ↓ 15 73 F HTN B,G 3.4 Normal 16 95 F HTN A,C,D 5.0 ↓ 17 74
Discussion
We observed 3 differences between cardiac performance during AF and overdrive pacing. First, stroke volume, as estimated by TVI, is greater during cardiac pacing than AF at the same cycle length (Figure 1). Second, the difference between TVI during AF and pacing narrows as cycle length increases. Third, decreasing cycle length during pacing does not increase TVI, regardless of baseline left ventricular function. These data agree with previous studies that report that cardiac output is increased
References (39)
- et al.
Rhythm or rate control in atrial fibrillation: Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
Lancet
(2000) - et al.
Antiarrhythmic drug therapy in the treatment of atrial fibrillation
Cardiol Clin
(1996) - et al.
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation
Am J Cardiol
(1993) - et al.
Proarrhythmic effects of the new antiarrhythmic flecainide acetate
Am Heart J
(1984) - et al.
Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial fibrillation Investigators
J Am Coll Cardiol
(1992) - et al.
Influence of left ventricular dysfunction on flecainide therapy
J Am Coll Cardiol
(1987) - et al.
Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation
J Am Coll Cardiol
(1997) - et al.
Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
J Am Coll Cardiol
(1997) - et al.
Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response
Am J Cardiol
(1996) - et al.
Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing
Am Heart J
(1995)
Effect of ventricular pacing on left ventricular function assessed by radionuclide angiography
Am Heart J
The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function
Am Heart J
Cardiac performance early after cardioversion from atrial fibrillation
Am Heart J
Interval-dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease
Am J Cardiol
Loss of adrenergic control of the force-frequency relation in heart failure secondary to idiopathic or ischemic cardiomyopathy
Am J Cardiol
Radiofrequency ablation of atrioventricular junction and pacemaker implantation versus modulation of atrioventricular conduction in drug refractory atrial fibrillation
Am J Cardiol
Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response
Am J Cardiol
Ablate and pace for drug refractory paroxysmal atrial fibrillation. Is ablation necessary?
Int J Cardiol
Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation
J Am Coll Cardiol
Cited by (4)
Accuracy of the Single Cycle Length Method for Calculation of Aortic Effective Orifice Area in Irregular Heart Rhythms
2019, Journal of the American Society of EchocardiographyCitation Excerpt :Despite the lower stroke volume with shorter R-R interval, there may be changes in contractility that could result in a larger EOA. Higher cardiac output is seen, for instance, with increasing regular heart rates achieved by pacing patients with AF.15 Ventricular contractility and myocardial performance in AF are also affected by the relationship between the preceding and the prepreceding cycle lengths: myocardial contractility and left ventricular function are directly related to the preceding R-R interval (RR1) and the ratio of the preceding interval to the prepreceding interval (RR1/RR2).16-20
Overdrive pacing for endovascular repair of an aortic arch aneurysm
2009, Journal of AnesthesiaAdverse effects of continuous ventricular pacing in patients with slower atrial fibrillation and normal left ventricular systolic function
2008, Annals of Noninvasive Electrocardiology
- *
Supported in part by National Institutes of Health General Clinical Research Center Grant No. MO1RR06192, and a grant from the Claude Pepper Center for Older Americans, No. 5P60-AG13631-03 (D.I.S.).
- **
Reprint requests: David I. Silverman, MD, Cardiology, University of Connecticut Health Center, 263 Farmington Ave, Farmington, CT 06030-1305.
- ★
E-mail: [email protected]